Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group41

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group29

Views

Views
January 20251
February 20251
March 202515
April 20252
May 20250
June 202510
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States3
Spain1
 

Top cities views

Views
Hong Kong10
Council Bluffs1
Los Angeles1